Inventor · disambiguated record
James A. Russell
Also filed as: RUSSELL JAMES · RUSSELL JAMES A
4 granted patents·14 pending applications·32 citations·filing 1979–2022
74Inventor score
Top patents by PatentIndex Score
18 records- 0180US4251325AProcess for the removal of hydroxyacetone from phenolBP CHEM INT LTD·Filed 1979·Granted Feb 17, 1981·17 cites·13 claims
- 0261US7820376B2Protein C polymorphismsUNIV BRITISH COLUMBIA·Filed 2003·Granted Oct 26, 2010·1 cites·8 claims
- 0361US2023066056A1Methods and uses for proprotein convertase subtilisin kexin 9 (pcsk9) inhibitorsANJI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0456US6203721B1Compounds useful for perhalogenoalkylation, reagent for implementing these compounds and synthesis method for obtaining these compoundsRHODIA CHIMIE SA·Filed 1997·Granted Mar 20, 2001·7 cites·1 claims
- 0555US6156922AMethod for the synthesis of an aromatic derivative ortho-disubstituted by a halogen atom other than fluorine and by a cyano groupRHODIA CHIMIE SA·Filed 1996·Granted Dec 5, 2000·7 cites·22 claims
- 0648US2006246451A1Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcomeRUSSELL JAMES A·Filed 2004·Application pending·0 cites
- 0743US2011104683A1Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcomeUNIV BRITISH COLUMBIA·Filed 2010·Application pending·0 cites
- 0843US2009298711A1Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjectsUNIV BRITISH COLUMBIA·Filed 2007·Application pending·0 cites
- 0943US2011020825A1Protein c polymorphisms useful as an indicator of patient outcomeUNIV BRITISH COLUMBIA·Filed 2010·Application pending·0 cites
- 1043US2022008499A1Compounds, compositions and methods for treating sepsisFERRING BV·Filed 2019·Application pending·0 cites
- 1141US2015140005A1Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) InhibitorsCYON THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1241US2011171200A1Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compoundWALLEY KEITH R·Filed 2009·Application pending·0 cites
- 1338US2011110930A1Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill SubjectsWALLEY KEITH R·Filed 2008·Application pending·0 cites
- 1438US2007281300A1Thrombomodulin (Thbd) Haplotypes Predict OutcomeRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1535US2009148458A1Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapyUNIV BRITISH COLUMBIA·Filed 2006·Application pending·0 cites
- 1632US2009176206A1Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patientsRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1732US2008026371A1Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject OutcomeRUSSELL JAMES·Filed 2005·Application pending·0 cites
- 1831US2011027184A1Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c-like compound administrationRUSSELL JAMES A·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James A. Russell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →